GO:0050770 regulation of axonogenesis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050770 (regulation of axonogenesis) is a biological_process term defined as any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
• Axonogenesis is a multistep process involving neuronal polarization, growth cone extension, cytoskeletal dynamics, and guidance cue sensing, and its regulation is essential for nervous system wiring.
• Key molecular regulators include Cdc42, which promotes axonogenesis of primary hippocampal neurons by inhibiting glycogen synthase kinase-3 beta, and CCL5, which is essential for axonogenesis and neuronal restoration after brain injury.
• Beyond the nervous system, axonogenesis-related programs are co-opted in cancer: RAB5B-CD109 endosomal trafficking promotes axonogenesis in KRAS-mutant pancreatic cancer, and Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1.
• Environmental and intercellular signals, including the maternal microbiome and neuro-immune interactions, can modulate fetal neurodevelopment and axonogenesis-related processes.
• Studying regulation of axonogenesis requires integrated approaches such as CRISPR knockout, point-mutation, knock-in, overexpression models, imaging, and transcriptomic/proteomic profiling.
Description
Regulation of axonogenesis (GO:0050770) is a Gene Ontology biological_process term that describes any process which modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron. Axonogenesis is a fundamental step in neural circuit formation, and its precise regulation ensures that neurons extend a single axon with correct length, trajectory, and connectivity. Because axonogenesis is dynamically controlled by intracellular signaling, cytoskeletal remodeling, and extracellular guidance cues, the GO term captures a broad set of regulatory inputs rather than a single molecular event. Researchers study GO:0050770 to understand normal neurodevelopment, neural regeneration, and pathological states in which axon growth is aberrantly activated or impaired. Recent work has also revealed that axonogenesis-related regulatory programs can be reactivated in non-neuronal contexts, including cancer, where they contribute to tumor innervation and progression. Thus, GO:0050770 provides a framework for dissecting how neurons and other cells control axon formation and how these controls go awry in disease.
regulation of axonogenesis At A Glance
| GO ID | GO:0050770 |
|---|---|
| GO term | regulation of axonogenesis |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron. |
| Major function | Controls the initiation, rate, and extent of axon formation during neural development and regeneration. |
| Related processes | Axon guidance, neuronal polarization, growth cone dynamics, cytoskeletal organization. |
| Representative regulators | Cdc42, CCL5, RAB5B, Netrin-1/NEO1, Tenascin C, Alpha5 nAChR subunit. |
| Disease relevance | Neurodevelopmental disorders, brain injury, cancer innervation, psoriasis neuro-immune interactions. |
What Is GO:0050770?
In our own words, GO:0050770 (regulation of axonogenesis) refers to any biological process that controls the initiation, rate, extent, or timing of axon formation. It does not describe the structural components of the axon itself, but rather the regulatory mechanisms, such as signaling pathways, cytoskeletal modulators, and guidance cues, that determine whether and how a neuron generates its axon. This term is a parent to more specific regulatory processes and is used to annotate gene products that modulate axonogenesis without being core structural constituents of the axon.
Why Is regulation of axonogenesis Important in Cell Biology?
Regulation of axonogenesis is central to nervous system development and repair, because the ability of a neuron to form and extend an axon determines its capacity to integrate into circuits and to regenerate after injury. Dysregulation of this process is linked to impaired neuronal restoration after brain injury and to aberrant neuro-immune interactions in inflammatory skin disease. In cancer, axonogenesis-related programs can be hijacked to promote tumor innervation and metastasis, as shown for RAB5B-CD109 trafficking in KRAS-mutant pancreatic cancer and Netrin-1/NEO1 signaling in pancreatic tumorigenesis. Understanding GO:0050770 therefore has broad implications for neurobiology, regenerative medicine, and oncology.
• Essential for neural circuit formation and proper brain wiring during development.
• Required for neuronal restoration and functional recovery after brain injury.
• Modulated by intercellular signals such as CCL5 and Tenascin C in neuro-immune contexts.
• Co-opted in cancer to promote tumor innervation and metastasis, e.g., in pancreatic cancer.
• Influenced by environmental factors such as the maternal microbiome during fetal neurodevelopment.
• Involves cytoskeletal regulators like Cdc42 that control growth cone dynamics and axon extension.
• Relevant to neurodevelopmental disorders and neurodegenerative conditions where axon growth is impaired.
• Provides a target for regenerative strategies aiming to restore neuronal connectivity.
• Offers mechanistic insight into neuro-immune crosstalk in diseases like psoriasis.
• Serves as a model for studying how developmental programs are reactivated in tumors.
What Happens During regulation of axonogenesis?
Neuronal polarization and axon specification
In simple terms: A neuron decides which of its extensions will become the axon.
Regulation of axonogenesis begins with neuronal polarization, during which one neurite is selected to become the axon while others become dendrites. This step is controlled by intracellular signaling that converges on cytoskeletal remodeling, and Cdc42 has been shown to promote axonogenesis of primary hippocampal neurons by inhibiting glycogen synthase kinase-3 beta. The specification of a single axon is a hallmark of regulated axonogenesis and is essential for directional signal transmission.
Growth cone extension and cytoskeletal dynamics
In simple terms: The growing tip of the axon moves forward by rearranging its internal skeleton.
Once specified, the axon extends via the growth cone, a motile structure whose actin and microtubule dynamics are tightly regulated. Cdc42 signaling contributes to this regulation by modulating GSK-3 beta activity, thereby influencing growth cone behavior and axon elongation. Proper regulation of these cytoskeletal events ensures that axons reach appropriate targets.
Extracellular guidance and neuro-immune signals
In simple terms: Outside signals tell the axon where to grow and when to stop.
Axonogenesis is modulated by extracellular cues, including chemokines and matrix proteins. CCL5 is essential for axonogenesis and neuronal restoration after brain injury, indicating that inflammatory mediators can directly regulate axon growth. Tenascin C-positive papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis, linking stromal-derived factors to regulation of axonogenesis in inflamed tissue. Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1, showing that classical guidance cues can regulate axonogenesis-like processes in cancer.
Endosomal trafficking and intracellular transport
In simple terms: Internal transport systems move molecules to the growing axon.
Regulation of axonogenesis also depends on intracellular trafficking. In KRAS-mutant pancreatic cancer, endosomal trafficking bypassed by the RAB5B-CD109 interplay promotes axonogenesis, demonstrating that vesicular transport pathways can regulate axon outgrowth. This highlights that regulation of axonogenesis is not limited to neurons but can be co-opted in other cell types.
Environmental and systemic modulation
In simple terms: Whole-body factors like the microbiome can influence how neurons grow.
Systemic factors can modulate axonogenesis-related processes. The maternal microbiome modulates fetal neurodevelopment in mice, indicating that maternal environmental signals can influence neuronal development, including axonogenesis. Such findings broaden the regulatory landscape of GO:0050770 beyond cell-intrinsic mechanisms.
Key Genes Involved in GO:0050770 regulation of axonogenesis
The following genes and proteins have been experimentally implicated in the regulation of axonogenesis (GO:0050770) or in closely related axonogenic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cdc42 | Promotes axonogenesis by inhibiting GSK-3 beta | Studied in primary hippocampal neurons to dissect cytoskeletal regulation of axon formation |
| CCL5 | Essential for axonogenesis and neuronal restoration after brain injury | Used as a model to link neuroinflammation to axon regeneration |
| RAB5B | Endosomal trafficking regulator promoting axonogenesis in KRAS-mutant pancreatic cancer | Studied in pancreatic cancer models to understand tumor innervation |
| CD109 | Interacts with RAB5B to bypass endosomal trafficking and promote axonogenesis | Investigated in KRAS-mutant pancreatic cancer for axonogenesis-like programs |
| Netrin-1 | Guidance cue promoting pancreatic tumorigenesis and innervation through NEO1 | Used to study axon guidance-like signaling in cancer |
| NEO1 | Receptor for Netrin-1 mediating innervation in pancreatic tumors | Target for understanding tumor innervation |
| Tenascin C | Expressed by papillary fibroblasts to facilitate neuro-immune interaction | Studied in psoriasis mouse models for neuro-immune crosstalk |
| Alpha5 nAChR subunit | Promotes intrahepatic cholangiocarcinoma metastasis | Relevant to neuro-axonal signaling in cancer progression |
| GSK-3 beta | Inhibited by Cdc42 to promote axonogenesis | Key kinase in axonogenesis regulation |
| Microbiome-derived factors | Modulate fetal neurodevelopment | Studied in maternal microbiome models |
| Neuroepithelial interaction molecules | Mediate interactions in cancer | Reviewed in the context of neuroepithelial interactions in cancer |
| CCL5 receptor (CCR5) | Potential mediator of CCL5-driven axonogenesis | Implied in CCL5-dependent neuronal restoration |
| RAB5 family GTPases | Regulate endosomal trafficking | Implicated in axonogenesis in cancer |
| Netrin receptors (DCC/UNC5) | Classical axon guidance receptors | Relevant to Netrin-1/NEO1 signaling |
| Tenascin C receptors (integrins) | Mediate neuro-immune interactions | Studied in psoriasis models |
| nAChR subunits | Modulate neuronal signaling | Linked to cholangiocarcinoma metastasis |
How Is regulation of axonogenesis Regulated?
Regulation of axonogenesis is controlled at multiple levels, including intracellular kinases such as GSK-3 beta, which is inhibited by Cdc42 to promote axonogenesis. Extracellular signals, including chemokines like CCL5 and matrix proteins like Tenascin C, modulate axon growth in injury and inflammation. In cancer, endosomal trafficking pathways involving RAB5B and CD109, as well as Netrin-1/NEO1 signaling, regulate axonogenesis-like programs. Systemic factors such as the maternal microbiome can also influence neurodevelopment, including axonogenesis-related processes.
regulation of axonogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCL5 | Brain injury and neuronal restoration | Knockout mouse model of brain injury |
| RAB5B | KRAS-mutant pancreatic cancer innervation | Pancreatic cancer cell lines with RAB5B knockout |
| Netrin-1 | Pancreatic tumorigenesis and innervation | Xenograft models with Netrin-1 overexpression |
| Tenascin C | Psoriasis neuro-immune interaction | Mouse model of psoriasis |
| Alpha5 nAChR | Intrahepatic cholangiocarcinoma metastasis | Cholangiocarcinoma cell lines with knockdown |
Brain injury and neuronal restoration
CCL5 is essential for axonogenesis and neuronal restoration after brain injury, indicating that regulation of axonogenesis is critical for recovery from neurological damage. Dysregulation of this process may impair regeneration and functional recovery.
Cancer innervation and metastasis
Axonogenesis-related programs are co-opted in cancer. RAB5B-CD109 endosomal trafficking promotes axonogenesis in KRAS-mutant pancreatic cancer, and Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1. Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis, further linking neuronal signaling to cancer progression. Neuroepithelial interactions in cancer are increasingly recognized as drivers of tumor behavior.
Neuro-immune and inflammatory skin disease
Tenascin C-positive papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis, suggesting that regulation of axonogenesis contributes to inflammatory skin pathology. This highlights the role of axonogenesis regulation beyond the nervous system.
Neurodevelopmental influences
The maternal microbiome modulates fetal neurodevelopment in mice, indicating that environmental factors can influence axonogenesis-related processes during development. Such modulation may have long-term consequences for brain wiring.
From regulation of axonogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Cdc42 promote axonogenesis via GSK-3 beta inhibition? | Cdc42 knockout or point-mutation in primary hippocampal neurons |
| Is CCL5 required for axonogenesis after brain injury? | CCL5 knockout mouse with brain injury |
| Does RAB5B-CD109 trafficking drive axonogenesis in pancreatic cancer? | RAB5B knockout in KRAS-mutant pancreatic cancer cells |
| Does Netrin-1/NEO1 signaling promote tumor innervation? | Netrin-1 overexpression or NEO1 knockout in pancreatic cancer models |
| How does Tenascin C mediate neuro-immune interaction in psoriasis? | Tenascin C knockout in mouse psoriasis model |
| Does maternal microbiome influence fetal axonogenesis? | Germ-free or antibiotic-treated mouse models |
How to Study the regulation of axonogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects | Testing necessity of Cdc42 in axonogenesis |
| CRISPR point mutation | Specific amino acid changes | Dissecting GSK-3 beta phosphorylation sites |
| CRISPR knock-in | Tagged or reporter alleles | Visualizing axonogenesis regulators in vivo |
| Overexpression | Gain-of-function effects | Testing Netrin-1-driven innervation |
| Live imaging | Axon growth dynamics | Studying growth cone behavior |
| RNA-seq | Transcriptional changes | Profiling axonogenesis programs in cancer |
| Proteomics | Protein abundance and interactions | Identifying RAB5B-CD109 complexes |
| Animal models | In vivo phenotypes | Brain injury and psoriasis studies |
CRISPR-based genetic perturbation
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes implicated in regulation of axonogenesis. For example, Cdc42 knockout or point mutations can be introduced in primary hippocampal neurons to dissect its role in axonogenesis. Similarly, RAB5B knockout in pancreatic cancer cells can test its role in axonogenesis-like programs.
Imaging and morphological analysis
High-resolution imaging of neuronal cultures and tissue sections allows quantification of axon length, growth cone dynamics, and polarization. Such approaches have been used to study Cdc42-dependent axonogenesis in hippocampal neurons and CCL5-dependent neuronal restoration after brain injury.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify global changes in gene expression and protein abundance upon perturbation of axonogenesis regulators. These methods are applicable to models such as RAB5B-CD109 trafficking in pancreatic cancer and Netrin-1/NEO1 signaling.
In vivo models of injury and disease
Animal models of brain injury, psoriasis, and cancer enable assessment of axonogenesis regulation in physiological contexts. CCL5 knockout mice have been used for brain injury studies, Tenascin C models for psoriasis, and pancreatic cancer models for Netrin-1/NEO1.
How CRISPR Can Be Used to Study GO:0050770 regulation of axonogenesis
Knockout
CRISPR knockout is used to eliminate genes such as Cdc42 or RAB5B to test their requirement for regulation of axonogenesis. For example, Cdc42 knockout in hippocampal neurons impairs axonogenesis, confirming its essential role. RAB5B knockout in pancreatic cancer cells can reveal its contribution to axonogenesis-like programs.
Point Mutation
Point mutations can be introduced to dissect specific phosphorylation or interaction sites. For instance, mutating GSK-3 beta phosphorylation sites can clarify how Cdc42 inhibits GSK-3 beta to promote axonogenesis. Such models provide mechanistic insight beyond simple knockout.
Knock-in
Knock-in of fluorescent tags or reporter cassettes allows real-time visualization of axonogenesis regulators. Tagging endogenous Cdc42 or RAB5B can reveal their localization during axon extension. This approach is valuable for studying dynamic processes in live cells.
Overexpression
Overexpression models are used to test gain-of-function effects, such as Netrin-1 overexpression promoting pancreatic tumor innervation. Overexpressing CCL5 or Tenascin C can enhance axonogenesis in injury or inflammation models. These models complement loss-of-function studies.
How EDITGENE Supports regulation of axonogenesis Research
Researchers studying regulation of axonogenesis-related genes often need to determine whether a candidate gene is causally involved in axon formation, growth, or regeneration. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout to precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for regulation of axonogenesis research.
Frequently Asked Questions About regulation of axonogenesis
What is GO:0050770 regulation of axonogenesis?
GO:0050770 is a Gene Ontology biological_process term defined as any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
What genes are involved in regulation of axonogenesis?
Key genes include Cdc42, CCL5, RAB5B, CD109, Netrin-1, NEO1, Tenascin C, and GSK-3 beta, as shown in studies of neuronal and cancer models.
How does Cdc42 regulate axonogenesis?
Cdc42 promotes axonogenesis of primary hippocampal neurons by inhibiting glycogen synthase kinase-3 beta.
What is the role of CCL5 in axonogenesis?
CCL5 is essential for axonogenesis and neuronal restoration after brain injury.
Is regulation of axonogenesis involved in cancer?
Yes, axonogenesis-related programs are co-opted in cancer; RAB5B-CD109 trafficking promotes axonogenesis in KRAS-mutant pancreatic cancer, and Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1.
How can I study regulation of axonogenesis in the lab?
CRISPR knockout, point mutation, knock-in, overexpression, imaging, and omics approaches are commonly used to study regulation of axonogenesis.
What diseases are linked to dysregulation of axonogenesis?
Brain injury, cancer innervation, psoriasis, and neurodevelopmental conditions have been linked to altered regulation of axonogenesis.
Does the maternal microbiome affect axonogenesis?
The maternal microbiome modulates fetal neurodevelopment in mice, which may include effects on axonogenesis-related processes.
What is the role of Netrin-1 in axonogenesis?
Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1, linking guidance cues to axonogenesis-like processes in cancer.
How does Tenascin C contribute to neuro-immune interactions?
Tenascin C-positive papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis, suggesting a role in regulating axonogenesis in inflamed tissue.
Conclusion
Regulation of axonogenesis (GO:0050770) is a fundamental biological process that controls axon formation and is essential for neural development, regeneration, and proper circuit wiring. Its dysregulation contributes to brain injury, cancer innervation, and inflammatory diseases, making it a key area of research. Advances in CRISPR-based models and omics technologies continue to uncover the molecular players and pathways that regulate axonogenesis, offering new opportunities for therapeutic intervention.
References
- 1. Vuong HE et al.. 2020. The maternal microbiome modulates fetal neurodevelopment in mice.. Nature 586(7828):281-286 PMID: 32968276
- 2. Fu Y et al.. 2024. Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis.. Signal Transduct Target Ther 9(1):63 PMID: 38453934
- 3. Ho MH et al.. 2024. CCL5 is essential for axonogenesis and neuronal restoration after brain injury.. J Biomed Sci 31(1):91 PMID: 39285280
- 4. Cai X et al.. 2023. Tenascin C(+) papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis.. Nat Commun 14(1):2004 PMID: 37037861
- 5. Zhang D et al.. 2024. Endosomal Trafficking Bypassed by the RAB5B-CD109 Interplay Promotes Axonogenesis in KRAS-Mutant Pancreatic Cancer.. Adv Sci (Weinh) 11(47):e2405092 PMID: 39488792
- 6. Ochiai Y et al.. 2025. Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1.. bioRxiv PMID: 40777309
- 7. Ayala G. 2023. Neuroepithelial Interactions in Cancer.. Annu Rev Pathol 18:493-514 PMID: 36323005
- 8. Li YT et al.. 2022. Cdc42 Promotes Axonogenesis of Primary Hippocampal Neurons by Inhibiting Glycogen Synthase Kinase-3β.. J Integr Neurosci 21(5):133 PMID: 36137969
